Increased Trading - Good SignMy fear as we entered the last half of December was the trading volumes of Oncolytics on the NASDAQ and TXM would drop through the floor. Distractions of the Holiday Season and year end close offs would reduce the buying pressure. Low trading volumes would allow the investment club to sell down the ladder and spike the stock price to produce a depressed year end close. With 5 days of trading remaining on the TXM, the interest in Oncolytics remains high. The combined trading volume yesterday was 320,000 shares. I can not believe the fools who are selling their shares with the short term 6 month outlook saying the stock price will double again. The smart money is buying.
Back on June 17, I posted Reduced Trading – Good Sign. The daily trading volumes were reducing by 50% to a combined 50,000 shares. Sellers were starting to not being fooled to give away their shares at unrealistic price of $3.00. The investment club had the advantage of limited outside buying pressure and being influential on this Discussion Board. Today is a different story. Outside interest in buying Oncolytics has increased 6 fold and January will see the trading volume increase to higher levels. The period to deceive the market is over. The market capitalization is moving to reflect the value of Reolysin and $500 million is only the beginning. Expect $1 billion by the time the snow melts in Winnipeg.
The last five trading days will be the last chance to buy Oncolytics before the market rally commences in earnest in January. Sellers will be better off spending time with family and friends than dumping their shares in the slow period before New Year's.